Időskori makuladegeneráció: vizsgálatok itt: Szlovákia

3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  Where

  Banska Bystrica, Bratislava, Nitra, Petrzalka, Poprad, Stare Mesto, Trebišov, Trenčín, Žilina

  Életkor

  50 év and over

  People

  304 worldwide

  Run by

  Amgen

  See details and how to joinNCT07614776 · EU 2025-523500-72-00
• 3. fázisNot yet taking people in Szlovákia
  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  Where

  Bratislava, Trenčín, Žilina

  Életkor

  50 év and over

  People

  561 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07007065 · EU 2024-512298-28-00
• 2/3. fázisTaking people
  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  Where

  Petrzalka, Trebišov, Trenčín, Žilina

  Életkor

  18 év and over

  People

  250 worldwide

  Run by

  Eyebiotech Limited

  See details and how to join2025-524894-17-00